Stay updated on Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added, and the entries 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page, with no visible changes to study history content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedDeleted the general operating-status notice from the page. Core trial history and linkable versions remain unchanged.SummaryDifference0.6%

- Check53 days agoChange DetectedThe screenshots indicate a cosmetic redesign of the Record History page with a different layout and styling, while the underlying content and version entries remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedUpdated operating status and version: old status/revision removed and new funding notice, current NIH Clinical Center status, and revision v3.2.0 added.SummaryDifference14%

- Check89 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.